Engaged Capital 13F, Q4 2023
Glenn Welling · quarter ending 31 December 2023 · filed 14 February 2024 · SEC CIK 1559771
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2023
Weights are against the whole filed book. Changes are in shares held, against the Q3 2023 filing.
| Company | Ticker | Value | % of book | vs Q3 2023 |
|---|---|---|---|---|
| EVOLENT HEALTH INC | EVH | $107.73M | 15.8% | +15% shares |
| SHAKE SHACK INC | SHAK | $101.34M | 14.8% | unchanged |
| V F CORP | VFC | $100.42M | 14.7% | +3% shares |
| NCR VOYIX CORPORATION | VYX | $84.86M | 12.4% | unchanged |
| UPBOUND GROUP INC | UPBD | $81.42M | 11.9% | -35% shares |
| NCR ATLEOS CORPORATION | NATL | $60.95M | 8.9% | new |
| PRA GROUP INC | PRAA | $52.68M | 7.7% | new |
| NEVRO CORP | $46.66M | 6.8% | new | |
| BRC INC | BRCC | $46.65M | 6.8% | +3% shares |
What changed since Q3 2023
Against the Q3 2023 filing, Engaged Capital opened 3 new positions, added to 3, trimmed 1, left 2 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000921895-24-000467, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.